Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: A random evaluation

19Citations
Citations of this article
18Readers
Mendeley users who have this article in their library.

Abstract

Purpose: To evaluate the role of intravenous methyl prednisolone in patients with solitary cysticercus granuloma with new-onset seizures. Methods: In this open-label, randomized, prospective, follow-up study, 52 patients with new-onset seizures and a single enhancing CT lesion of cysticercus were randomly divided in two groups to receive either intravenous methyl prednisolone for 5 days along with antiepileptic drug (n = 25) or antiepileptic drug monotherapy (n = 27) alone. The patients were followed up for at least for 9 months. Repeat CT scans were performed after 2 months. Results: After 2 months, lesion disappeared in 60% patients of intravenous methyl prednisolone group and 18.5% patients receiving only antiepileptic drug (p = 0.001). As far as seizure recurrence was concerned, a lower number (16% versus 33%) of intravenous methyl prednisolone treated patient had recurrence, the difference was insignificant. Conclusion: Intravenous methyl prednisolone therapy helps in early resolution of solitary cysticercus granuloma. © 2006 British Epilepsy Association.

Cite

CITATION STYLE

APA

Prakash, S., Garg, R. K., Kar, A. M., Shukla, R., Agarwal, A., Verma, R., & Singh, M. K. (2006). Intravenous methyl prednisolone in patients with solitary cysticercus granuloma: A random evaluation. Seizure, 15(5), 328–332. https://doi.org/10.1016/j.seizure.2006.03.003

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free